FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AAGILENT TECHNOLOGIES, INC.

Inspect →

AAAlcoa Corp

Inspect →

AAAUGoldman Sachs Physical Gold ETF

Inspect →

AACAres Acquisition Corp III

Inspect →

AACGATA Creativity Global

Inspect →

AACIArmada Acquisition Corp. III

Inspect →

AACOAbony Acquisition Corp. I

Inspect →

AACPApogee Acquisition Corp

Inspect →

AADXApplied Aerospace & Defense, Inc.

Inspect →

AAGHAmerica Great Health

Inspect →

AALAmerican Airlines Group Inc.

Inspect →

AAMEATLANTIC AMERICAN CORP

Inspect →

03 / FINANCIAL CHANGES

Ernexa Therapeutics Inc. ERNA

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-06 · Retrieved: 2026-11-10

Compared with the same period of the prior year, ending 2025-09-30.

Revenue—

USD million

No comparable prior-year value

Net income-2.94

USD million

Change year over year: -1.70

Operating cash flow-3.17

USD million

Change year over year: -1.90

Total liabilities2.75

USD million

Change year over year: +0.15

Total assets7.10

USD million

Change year over year: +0.93

Liabilities / assets: 38.8% · Change: -3.4 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-03-13 · Retrieved: 2026-11-10

Compared with the same period of the prior year, ending 2024-12-31.

Revenue—

USD million

No comparable prior-year value

Net income-14.08

USD million

Change year over year: +30.46

Operating cash flow-7.02

USD million

Change year over year: +8.82

Total liabilities3.43

USD million

Change year over year: -0.14

Total assets5.83

USD million

Change year over year: +0.57

Liabilities / assets: 58.8% · Change: -8.9 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
IMNM ↗	2025-12-31	6.94	-3,060.0%	-2,750.6%
ABUS ↗	2025-12-31	14.08	-237.9%	-281.5%
TNXP ↗	2025-12-31	13.11	-946.2%	-761.8%
KURA ↗	2025-12-31	67.48	-412.9%	-94.9%
WHWK ↗	2025-12-31	7.15	-288.3%	-1,363.7%
IBIO ↗	2026-06-30	0.10	-33,044.0%	-23,218.0%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

AMBQ ↗

Ambiq Micro, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

PAYS ↗

Paysign, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

LAND ↗

GLADSTONE LAND Corp

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

AMBO ↗

Ambow Education Holding Ltd.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

ELMD ↗

Electromed, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

ABUS ↗

Arbutus Biopharma Corp

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

MRDN ↗

Meridian Holdings Inc./NV

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

KURA ↗

Kura Oncology, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

IBIO ↗

iBio, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

SNWV ↗

SANUWAVE Health, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

BNGO ↗

Bionano Genomics, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

GEVO ↗

Gevo, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →